FDA Approves Novavax COVID-19 Vaccine with Limits


FDA Approves Novavax COVID-19 Vaccine with Limits

Reading

Read this text and listen to it at the same time. If you don’t know a word click it to see explanation, hear pronunciation or add it to vocabulary.
FDA Approves Novavax COVID-19 Vaccine with Limits

The FDA has approved the Novavax COVID-19 vaccine. This approval has some special rules about who can get it. This was a long wait for the Novavax company.

Novavax makes a protein-based vaccine, which is different. Before, it was only allowed for people ages 12 and up. The FDA now allows it fully, but only for some people.

Adults over 65 can get the Novavax vaccine fully approved. People ages 12-64 with health problems can also get it. Pfizer and Moderna vaccines are already fully approved for more people.

Experts will soon talk about yearly COVID vaccines. They will discuss who should get them each year. The Novavax decision might show what the government already thinks.

The FDA did not explain why there are rules for the vaccine. Some people think it is because of worries about vaccines. Novavax tested the vaccine and showed it was safe and worked well.


Questions

Answer the questions to the text. Speak or write, you choose. AI will assess your answers.

What vaccine did the FDA approve?

The FDA approved the Novavax COVID-19 vaccine.

Who can get the Novavax vaccine?

Adults over 65 and people ages 12-64 with health problems can get the Novavax vaccine.

What will experts discuss soon?

Experts will discuss yearly COVID vaccines and who should get them each year.


Describing image

Look at the article image and describe what you see on it. You may either speak or write your answer there.


Discussion

Discuss this article with your AI tutor to practice. Your tutor will help you with vocabulary and grammar.

Read a new article every day and
discuss it with AI at lingolette.com
All content and tasks are generated by AI inspired by a real publication.